4.7 Article

Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2

Journal

LANCET INFECTIOUS DISEASES
Volume 21, Issue 6, Pages E163-E169

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/S1473-3099(20)30837-9

Keywords

-

Funding

  1. Swiss National Science Foundation [320030_176233]
  2. European Union Horizon 2020 research and innovation programme [101003688]
  3. Canadian Institutes for Health Research COVID-19 Rapid Research Funding Opportunity [02179-000]
  4. Swiss National Science Foundation (SNF) [320030_176233] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

The transmission of SARS-CoV-2 from asymptomatic individuals contributes to pandemic spread, but accurately estimating this proportion is hindered by methodological issues like incomplete symptom assessment and inadequate follow-up. Recommendations regarding definitions, detection, documentation, and follow-up are provided to improve the identification and evaluation of people with persistently asymptomatic SARS-CoV-2 infection and their contacts. Accurate characterization of the persistently asymptomatic fraction of infected individuals could shed light on COVID-19 pathogenesis and transmission dynamics, and inform public health responses.
People with persistently asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection experience no symptoms throughout the course of infection, and pre-symptomatic individuals become infectious days before they report symptoms. Transmission of SARS-CoV-2 from individuals without symptoms contributes to pandemic spread, but the extent of transmission from persistently asymptomatic individuals remains unknown. We describe three methodological issues that hinder attempts to estimate this proportion. First, incomplete symptom assessment probably overestimates the asymptomatic fraction. Second, studies with inadequate follow-up misclassify pre-symptomatic individuals. Third, serological studies might identify people with previously unrecognised infection, but reliance on poorly defined antibody responses and retrospective symptom assessment might result in misclassification. We provide recommendations regarding definitions, detection, documentation, and follow-up to improve the identification and evaluation of people with persistently asymptomatic SARS-CoV-2 infection and their contacts. Accurate characterisation of the persistently asymptomatic fraction of infected individuals might shed light on COVID-19 pathogenesis and transmission dynamics, and inform public health responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available